Antiretroviral therapy increases thymic output in children with HIV

AIDS

Volumn 28, Issue 2, 2014, Pages 209-214

  Sandgaard, Katrine S ^a   Lewis, Joanna ^a,b   Adams, Stuart ^c   Klein, Nigel ^a   Callard, Robin ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Antiretroviral therapy; HIV; Immune reconstitution; Paediatrics,T cell proliferation; T cells; T cell receptor excision circles; Thymic output; Treatment guidelines

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIVISION; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THYMIC OUTPUT; THYMUS FUNCTION; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ANTI-RETROVIRAL AGENTS; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; MALE; T-LYMPHOCYTES; THYMUS GLAND;

EID: 84892373987     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000063     Document Type: Article

References (31)

1. Bains I, Antia R, Callard R, Yates AJ. Quantifying the development of the peripheral naive CD4R T cell pool in humans. Blood 2009; 113:5480-5487.
2. Steinmann GG, Klaus B, Muller-Hermelink HK. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol 1985; 22: 563-575.
3. Bains I, Thiebaut R, Yates AJ, Callard RE. Quantifying Thymic Export: combining models of naive T cell proliferation and TREC dynamics gives an explicit measure of thymic output. J Immunol 2009; 183:4329-4336.
4. Hazenberg MD, Otto SA, van Rossum AM, Scherpbier HJ, de Groot R, Kuijpers TW, et al. Establishment of the CD4R T-cell pool in healthy children and untreated children infected with HIV-1. Blood 2004; 104:3513-3519.
5. den Braber I, Mugwagwa T, Vrisekoop N, Westera L, Mogling R, Bregje de Boer A, et al. Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity 2012; 36:288-297.
6. Yin L, Kou ZC, Rodriguez C, Hou W, Goodenow MM, Sleasman JW. Antiretroviral therapy restores diversity in the T-cell receptor Vbeta repertoire of CD4 T-cell subpopulations among human immunodeficiency virus type 1-infected children and adolescents. Clin Vaccine Immunol 2009; 16: 1293-1301.
7. Connors M, Kovacs JA, Krevat S, Gea-Banacloche JC, Sneller MC, Flanigan M, et al. HIV infection induces changes in CD4R T-cell phenotype and depletions within the CD4R T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997; 3:533-540.
8. Vigano A, Vella S, Principi N, Bricalli D, Sala N, Salvaggio A, et al. Thymus volume correlates with the progression of vertical HIV infection. AIDS 1999; 13:F29-34.
9. Steffens CM, Smith KY, Landay A, Shott S, Truckenbrod A, Russert M, et al. T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIVinfected and HIV-uninfected individuals. AIDS 2001; 15: 1757-1764.
10. Douek DC, Betts MR, Hill BJ, Little SJ, Lempicki R, Metcalf JA, et al. Evidence for increased T cell turnover and decreased thymic output in HIV infection. J Immunol 2001; 167:6663-6668.
11. Douek D. Thymic output and HIV infection: on the right TREC. Immunity 2004; 21:744-745.
12. Hazenberg MD, Verschuren MC, Hamann D, Miedema F, van Dongen JJ. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med 2001; 79:631-640.
13. Hazenberg MD, Borghans JA, de Boer RJ, Miedema F. Thymic output: a bad TREC record. Nat Immunol 2003; 4:97-99.
14. Hazenberg MD, Otto SA, Cohen Stuart JW, Verschuren MC, Borleffs JC, Boucher CA, et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med 2000; 6:1036-1042.
15. Vrisekoop N, van Gent R, de Boer AB, Otto SA, Borleffs JC, Steingrover R, et al. Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging. J Immunol 2008; 181:1573-1581.
16. Ribeiro RM, de Boer RJ. The contribution of the thymus to the recovery of peripheral naive T-cell numbers during antiretroviral treatment for HIV infection. J Acquir Immune Defic Syndr 2008; 49:1-8.
17. Gerstel-Thompson JL, Wilkey JF, Baptiste JC, Navas JS, Pai SY, Pass KA, et al. High-throughput multiplexed T-cell-receptor excision circle quantitative PCR assay with internal controls for detection of severe combined immunodeficiency in population-based newborn screening. Clin Chem 2010; 56:1466-1474.
18. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396:690-695.
19. Linderkamp O, Versmold HT, Riegel KP, Betke K. Estimation and prediction of blood volume in infants and children. Eur J Pediatr 1977; 125:227-234.
20. Team RDC. R: a language and environment for statistical computing. Vienna: R Foundation for Statisitcal Computing; 2011.
21. Anthony KB, Yoder C, Metcalf JA, DerSimonian R, Orenstein JM, Stevens RA, et al. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. JAcquir Immune Defic Syndr 2003; 33:125-133.
22. Haynes BF, Hale LP, Weinhold KJ, Patel DD, Liao HX, Bressler PB, et al. Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Investig 1999; 103: 453-460.
23. Zeng M, Paiardini M, Engram JC, Beilman GJ, Chipman JG, Schacker TW, et al. Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution. Blood 2012; 120:1856-1867.
24. Lewis J, Walker AS, Castro H, De Rossi A, Gibb DM, Giaquinto C, et al. Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. J Infect Dis 2012; 205:548-556.
25. Resino S, Resino R, Micheloud D, Gurbindo Gutierrez D, Leon JA, Ramos JT, et al. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up. Clin Infect Dis 2006; 42:862-869.
26. Patel K, Hernan MA, Williams PL, Seeger JD, McIntosh K, Dyke RB, et al. Long-term effects of highly active antiretroviral therapy on CD4R cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis 2008; 46:1751-1760.
27. Newell ML, Patel D, Goetghebuer T, Thorne C. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? J Infect Dis 2006; 193:954-962.
28. Walker AS, Doerholt K, Sharland M, Gibb DM. Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study. AIDS 2004; 18: 1915-1924.
29. Puthanakit T, Kerr S, Ananworanich J, Bunupuradah T, Boonrak P, Sirisanthana V. Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy. Pediatr Infect Dis J 2009; 28:488-492.
30. Garrido C, Rallón N, Soriano V, Lopez M, Zahonero N, de Mendoza C, Benito JM. Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir. AIDS 2012; 26:551-557.
31. DeJesus E, Rockstroh JK, Lennox JL, Saag MS, Lazzarin A, Zhao J, et al., and STARTMRK Investigators. Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-na?̈ve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK. HIV Clin Trials 2012; 3:228-232.